Target intelligence / Profile preview

Osmotic gradient via dextrose-induced ultrafiltration across the peritoneum

Molecular classification
Other (physicochemical process; not a molecule, receptor, or enzyme)
01

Overview

Dextrose-induced osmotic ultrafiltration is a core mechanism of peritoneal dialysis, where **high concentrations of dextrose in dialysate establish an osmotic gradient across the peritoneal membrane**. This gradient drives water from the blood vessels into the peritoneal cavity, removing excess fluid and solutes. The process relies on water transport through inter-endothelial pores and aquaporin-1 water channels, with effectiveness based on peritoneal membrane characteristics and dextrose concentration. While vital for fluid management in renal failure, long-term exposure to high glucose concentrations can lead to peritoneal membrane fibrosis, reduced efficacy (ultrafiltration failure), and metabolic complications such as hyperglycemia. Alternative non-glucose osmotic agents like icodextrin may be used to mitigate some risks.

Other names
Dextrose-induced peritoneal ultrafiltrationGlucose-based osmotic ultrafiltrationPeritoneal dialysis osmotic gradient
02

Mechanism of action

Dextrose in dialysate establishes an **osmotic gradient** causing water from blood vessels to move into the peritoneal cavity Water is transported via inter-endothelial pores and aquaporin-1 channels

03

Biological functions

Fluid removal (ultrafiltration)Maintenance of body fluid balanceFacilitates removal of solutes during renal failure
04

Disease associations

Chronic kidney disease (renal failure)Volume overload in dialysis patients
05

Safety considerations

Glucose absorption: risk of hyperglycemia, increased caloric loadPeritoneal membrane damage: long-term exposure can cause fibrosis and ultrafiltration failureImpaired fluid removal: ultrafiltration failure in long-term dialysisPotential for infections: peritonitis risk in peritoneal dialysis
06

Interacting drugs

Dextrose-based peritoneal dialysis solutions (e.g., DIANEAL)

1 more in the full profile.

07

Biomarkers

Peritoneal equilibration test (PET; for membrane transport characteristics)Ultrafiltration volume (UF)

Beyond the preview

Go deeper on Osmotic gradient via dextrose-induced ultrafiltration across the peritoneum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osmotic gradient via dextrose-induced ultrafiltration across the peritoneum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call